Toshimitsu Niwa
- Nephrology top 0.05%
- Molecular Biology top 1%
- Clinical Biochemistry top 0.05%
- Physiology top 1%
- Endocrinology, Diabetes and Metabolism top 0.5%
- Co-authors
- Hidehisa ShimizuAtsushi EnomotoFuyuhiko NishijimaTakashi MiyazakiKentaro TakiFumio TakayamaYoshinari TsurutaZohra Tumur
- Topics
- Advanced Glycation End Products research (62 papers)Dialysis and Renal Disease Management (50 papers)Metabolism and Genetic Disorders (30 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Toshimitsu Niwa
305 papers receiving 12.8k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Nephrology 5.1k
- Molecular Biology 4.1k
- Clinical Biochemistry 2.5k
- Physiology 1.9k
- Endocrinology, Diabetes and Metabolism 1.5k
Countries citing papers authored by Toshimitsu Niwa
This map shows the geographic impact of Toshimitsu Niwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshimitsu Niwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshimitsu Niwa more than expected).
Fields of papers citing papers by Toshimitsu Niwa
This network shows the impact of papers produced by Toshimitsu Niwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshimitsu Niwa. The network helps show where Toshimitsu Niwa may publish in the future.
Co-authorship network of co-authors of Toshimitsu Niwa
This figure shows the co-authorship network connecting the top 25 collaborators of Toshimitsu Niwa. A scholar is included among the top collaborators of Toshimitsu Niwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshimitsu Niwa. Toshimitsu Niwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 62 | |
| 6 | 103 | |
| 7 | 84 | |
| 8 | Genotype announcement in a genetic polymorphism study for health checkup examinees at Nagoya University Hospital. | 4 |
| 9 | 12 | |
| 10 | 19 | |
| 11 | 16 | |
| 12 | 5 | |
| 13 | 9 | |
| 14 | Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA). | 21 |
| 15 | 48 | |
| 16 | 274 | |
| 17 | Molecular Cloning of Rat ZAKI-4 Gene | 3 |
| 18 | [Early diagnosis of acute mesenteric artery occlusion--clinical and experimental study]. | 1 |
| 19 | 26 | |
| 20 | 1 |
About Toshimitsu Niwa
Toshimitsu Niwa is a scholar working on Clinical Biochemistry, Nephrology and Biochemistry, having authored 311 papers that have together received 13.0k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (62 papers), Dialysis and Renal Disease Management (50 papers) and Metabolism and Genetic Disorders (30 papers). The work is most often cited by research in Nephrology (5.1k citations), Clinical Biochemistry (2.5k citations) and Biochemistry (705 citations). Toshimitsu Niwa has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Hidehisa Shimizu, Atsushi Enomoto, Fuyuhiko Nishijima, Takashi Miyazaki, Kentaro Taki, Fumio Takayama, Yoshinari Tsuruta, Zohra Tumur, Kaoru Shimokata and Hitoshi Endou. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.